JP2025513031A5 - - Google Patents

Info

Publication number
JP2025513031A5
JP2025513031A5 JP2024559705A JP2024559705A JP2025513031A5 JP 2025513031 A5 JP2025513031 A5 JP 2025513031A5 JP 2024559705 A JP2024559705 A JP 2024559705A JP 2024559705 A JP2024559705 A JP 2024559705A JP 2025513031 A5 JP2025513031 A5 JP 2025513031A5
Authority
JP
Japan
Prior art keywords
group
groups
cyclic hydrocarbon
alkyl
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024559705A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513031A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/088285 external-priority patent/WO2023198172A1/zh
Publication of JP2025513031A publication Critical patent/JP2025513031A/ja
Publication of JP2025513031A5 publication Critical patent/JP2025513031A5/ja
Pending legal-status Critical Current

Links

JP2024559705A 2022-04-15 2023-04-14 オキサジアゾール化合物、それを含む医薬組成物及びその使用 Pending JP2025513031A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210401425.8 2022-04-15
CN202210401425 2022-04-15
PCT/CN2023/088285 WO2023198172A1 (zh) 2022-04-15 2023-04-14 噁二唑化合物、包含其的药物组合物及其用途

Publications (2)

Publication Number Publication Date
JP2025513031A JP2025513031A (ja) 2025-04-22
JP2025513031A5 true JP2025513031A5 (https=) 2026-04-21

Family

ID=88329075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024559705A Pending JP2025513031A (ja) 2022-04-15 2023-04-14 オキサジアゾール化合物、それを含む医薬組成物及びその使用

Country Status (10)

Country Link
US (1) US20250257060A1 (https=)
EP (1) EP4509506A4 (https=)
JP (1) JP2025513031A (https=)
KR (1) KR20250003703A (https=)
CN (1) CN119032089A (https=)
AU (1) AU2023254010A1 (https=)
CA (1) CA3247934A1 (https=)
IL (1) IL316301A (https=)
TW (1) TW202400147A (https=)
WO (1) WO2023198172A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202345813A (zh) 2022-04-08 2023-12-01 美商艾科尼佐療法股份有限公司 㗁二唑hdac6抑制劑及其用途
TW202513061A (zh) * 2023-09-28 2025-04-01 大陸商勤浩醫藥(蘇州)有限公司 一種hdac6抑制劑的結晶形式及其製備方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018165520A1 (en) * 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
CN111032651A (zh) * 2017-07-31 2020-04-17 武田药品工业株式会社 杂环化合物
US12084436B2 (en) * 2019-01-30 2024-09-10 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2021060567A1 (en) * 2019-09-27 2021-04-01 Takeda Pharmaceutical Company Limited 2-isoindol-1,3,4-oxadiazole derivatives useful as hdac6 inhibitors
WO2021255091A1 (en) * 2020-06-19 2021-12-23 Bayer Aktiengesellschaft 1,3,4-oxadiazoles and their derivatives as fungicides

Similar Documents

Publication Publication Date Title
JP2025513031A5 (https=)
EP4001276B1 (en) Aurora kinase inhibitor and use thereof
JP2021522206A5 (https=)
JP2019519476A5 (https=)
JP2017501234A5 (https=)
JP2013542994A5 (https=)
JP2009539848A5 (https=)
IL302997B2 (en) Purine inhibitors
JP2012520324A5 (https=)
AU2015315687B2 (en) P2X7 modulators
AU2015414743B2 (en) Process for the preparation of kinase inhibitors and intermediates thereof
JP2015502387A5 (https=)
JP2025516367A (ja) Parp1を選択的に阻害するフルオロキノキサリノン誘導体
JP2009534407A5 (https=)
JP2023533203A5 (https=)
JP2017508733A5 (https=)
WO2004007471A1 (ja) N−フェニル−(2r,5s)ジメチルピペラジン誘導体
JP2012524107A5 (https=)
EA031614B1 (ru) Трициклические атропоизомерные соединения
JP2017516785A5 (https=)
JP2019510801A5 (https=)
JP2024511389A5 (https=)
KR102295416B1 (ko) 1-(피페라진-1-일)-2-([1,2,4]트리아졸-1-일)-에타논 유도체
EP4021886A1 (en) Substituted urea dihydroorotate dehydrogenase inhibitors
JP5847362B1 (ja) シクロヘキシルピリジン誘導体